Indo-US agree on five-year extension of Vaccine Action Program

2017-04-17 09:31:58

A Joint Statement for extension of VAP program for a period of five years till 2022 was signed between Prof. K. Vijay Raghavan, Secretary DBT and Dr. Anthony S. Fauci, Director, NIAID, NIH, USA.By Team ABLEAt the recently held 29th Joint Working Group meeting of the Vccine Action Program signed by USA and India, Dr Anthony S Fauci, Director of National Institute of Allergy and Infectious Diseases

Read more

Emerging economies to become biopharmaceutical analytical instrumentation manufacturing hubs: Frost & Sullivan

2017-04-17 09:31:06

Global Biopharmaceutical Analytical Instrumentation Market Forecast to 2022, recent analysis from Frost & Sullivan\'s Test & Measurement Growth Partnership Subscription, finds that the market generated revenues of $1,092 million in 2015, and this is expected to grow at a compound annual growth rate (CAGR) of 7.2 percent until 2022. By Team ABLEBiosimilars are driving rapid double-digit gro

Read more

Bill and Melinda Gates’ Grand Challenges Explorations announce reminder on application deadline date

2017-04-17 09:29:18

The Bill & Melinda Gates Foundation has announced a reminder that the application deadline for the latest round of Grand Challenges Explorations is May 3, 2017. By Team ABLEThe Bill & Melinda Gates Foundation has announced a reminder that the application deadline for the latest round of Grand Challenges Explorations is May 3, 2017. Grand Challenges Explorations fosters early-stage discover

Read more

DCGI approves Regenerative Medical Services’ Chondron ACI cell therapy product

2017-04-17 09:26:03

Regenerative Medical Services’ Chondron ACI cell therapy product is indicated for use of articular cartilage defects of knee, ankle & shoulder joints.By Team ABLEThe Drug Controller General of India (DCGI) has granted authorization to Mumbai-based Regenerative Medical Services Regrow (RMS Regrow) to market India’s first  product, Chondron ACI.According to Regrow, Chondron ACI is indic

Read more

M3 Biotechnology receives funding from Alzheimer’s Drug Discovery Foundation for human trials

2017-04-17 09:23:46

As the first investor in M3 Biotechnology, the Alzheimer’s Drug Discovery Foundation (ADDF) helped validate the therapeutic potential of M3’s drug candidate for Alzheimer’s disease.By Team ABLEAs the first investor in M3 Biotechnology, the Alzheimer’s Drug Discovery Foundation (ADDF) helped validate the therapeutic potential of M3’s drug candidate for Alzheimer’s disease. With a second

Read more

Roche launches antibody test for diagnosis of challenging prostate cancer cases

2017-04-17 09:21:41

Roche\'s anti-p504s (SP116) Primary Antibody is a tool to aid clinicians in making a more accurate diagnosis with a smaller tissue sampleBy Team ABLERoche has announced the global launch of the anti-p504s (SP116) Rabbit Monoclonal Primary Antibody for prostate cancer diagnosis. This antibody has been validated for use in a dual stain with the VENTANA Basal Cell Cocktail (34ßE12+p63) to aid in dis

Read more

Dr V Mohan’s Diabetes Specialties Centre raises Rs 66 crore to further expand facilities in India

2017-04-13 07:17:10

Dr Mohan’s Diabetes Specialities Centre has raised a Series-A investment round of $10.23 million (Rs 66 crore) from Lok Capital and Evolvence India Fund By Team ABLEChennai-headquartered Diabetologist Dr V Mohan’s Diabetes Specialties Centre has raised Series-A investment round of $10.23 million (Rs 66 crore) from Lok Capital and Evolvence India Fund, a private equity fund. This has been noted

Read more

Union Minister J P Nadda reviews preparedness regarding Dengue and Chikungunya

2017-04-13 07:16:24

States asked to mount aggressive IEC campaigns for creating awareness on prevention & control of vectors By Team ABLEMr J P Nadda, Union Minister for Health and Family Welfare, held a high-level meeting to review the preparedness of the Ministry and Central Government Hospitals for prevention and control of dengue and chikungunya in the country. During the meeting, Mr Nadda asked the States fo

Read more

NIH scientists advance understanding of herpesvirus infection

2017-04-13 07:14:22

National Institutes of Health scientists have identified a set of protein complexes that are recruited to viral genes and stimulate both initial infection and reactivation from latency. By Team ABLEHerpes simplex virus (HSV) infections last a lifetime. Once a person has been infected, the virus can remain dormant (latent) for years before periodically reactivating to cause recurrent disease. This

Read more

Indian, Australian Prime Ministers inaugurate TERI-Deakin University’s joint Nano Biotechnology Research Centre in Gurgaon

2017-04-13 06:21:32

The TERI-Deakin Nano Biotechnology Centre (TDNBC), established at Gwal Pahari, Gurgaon, aims to support and nurture innovative ideas for existing problems of Indian agriculture amongst other sectors.By Team ABLEHon’ble Prime Minister Narendra Modi along with Australian Prime Minister Malcolm Turnbull, inaugurated the world’s most advanced nanobiotechnology research centre, a joint venture betw

Read more